Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
Natalija Budimir, Graham D. Thomas, Joseph S. Dolina, et al.
Cancer Immunology Research (2021) Vol. 10, Iss. 2, pp. 146-153
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Kun Pang, Zhenduo Shi, Liuya Wei, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100907-100907
Closed Access | Times Cited: 117
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
Wei Li, Fenglei Wu, Shaolin Zhao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 49-57
Open Access | Times Cited: 95
Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction
Ruifang Wang, Maosong Qiu, Lei Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 63
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
Alex G. Hamilton, Kelsey L. Swingle, Ryann A. Joseph, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 30
Open Access | Times Cited: 45
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 30
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 23
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
Daniiar Dyikanov, A. V. Zaitsev, Т.В. Васильева, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 759-779.e12
Open Access | Times Cited: 22
Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
Yujie Zhao, Xu Liu, Xinyu Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
The strategies to cure cancer patients by eradicating cancer stem-like cells
Yansui Mai, Jiyan Su, Chuan Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114824-114824
Open Access | Times Cited: 25
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer
Shuning Ding, Q. L. Niu, Qingchen Zhu, et al.
Cancer Communications (2023) Vol. 43, Iss. 6, pp. 661-684
Open Access | Times Cited: 22
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Kelly D. Moynihan, Manu P. Kumar, Hussein Sultan, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1206-1225
Open Access | Times Cited: 15
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Sequential immunotherapy: towards cures for autoimmunity
Francisco Ramírez‐Valle, Joseph Maranville, Sophie Roy, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 501-524
Closed Access | Times Cited: 10
Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy
Yonghua Gong, Wenyue Gao, Jinyang Zhang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Tobacco-induced hyperglycemia promotes lung cancer progression via cancer cell-macrophage interaction through paracrine IGF2/IR/NPM1-driven PD-L1 expression
Hyun-Ji Jang, Hye‐Young Min, Yun Pyo Kang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients
Luong T. H. Nguyen, Jingjing Zhang, Xilal Y. Rima, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 33
Role of regulation of PD-1 and PD-L1 expression in sepsis
Teng Zhang, Yujing Li, Tao Ma
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
PD-1/PD-L1 axis in organ fibrosis
Youliang Zhao, Yaqian Qu, Changfu Hao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy
Nana Bie, Tuying Yong, Zhaohan Wei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features
Enrico Berrino, Maria Costanza Aquilano, Emanuele Valtorta, et al.
Modern Pathology (2023) Vol. 36, Iss. 2, pp. 100012-100012
Open Access | Times Cited: 19
Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study
Yun Yang, Jun Li, Chao Jing, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 11, pp. 1205-1215
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top